October 19, 2015
This course will provide the National Institute on Drug Abuse and Substance Abuse and Mental Health Services Administration’s Blending Initiative product, entitled “Buprenorphine Treatment: A Training for Multdisciplinary Professionals”. The primary goal of this training package is to create awareness among addiction professionals about buprenorphine in the treatment of opioid dependence. The course includes information about what to expect when someone is treated with this medication, information about the legislation that permits office – based buprenorphine treatment, the science of addiction, the mechanism of buprenorphine, patient selection criteria, and associated patient, counseling, and therapeutic issues. In addition to the NIDA product presentation on buprenorphine, Methadone and Vivitrol, and the criteria for determining appropriate candidates for each therapy for opiate dependence, will be reviewed. Other current medications approved for the treatment of non-opiate substance use disorders will also be addressed.
Time: 9 am - 4 pm
6 CEU's: CD, SW, MHC
Instructor: Michael Gaudet, LICSW
Medication Assisted Treatment and Recovery for Substance Use Disorders